Mirae Asset Global Etfs Holdings Ltd. Erasca, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Erasca, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 112,565 shares of ERAS stock, worth $176,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,565
Previous 106,221
5.97%
Holding current value
$176,727
Previous $289,000
2.42%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ERAS
# of Institutions
152Shares Held
227MCall Options Held
10.9KPut Options Held
65.1K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$30.4 Million2.92% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.7MShares$26.2 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$25.5 Million6.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$19.9 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA12.5MShares$19.6 Million4.12% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $192M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...